NP-3022

N/A

Report date: 2024/01/03 15:38:50

Base Information

Drug NameNP-3022
Drug Alias NameNP-3022NP3022
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-galactosidase modulators
TargetsBeta-galactosidase
Therapy Area/IndicationsMucopolysaccharidosis IV
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovel Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNovel Pharma Inc
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis IV
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A